AnGes, Inc.TSE 4563

アンジェス株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
—
FY ending Dec 2025
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥36.7M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Central Tanshin Co., Ltd. 10,000,000 2.57% — —
2 MSIP Client Securities 9,631,571 2.47% — —
3 日本証券金融株式会社 7,389,300 1.89% — —
4 INTERACTIVE BROKERS LLC 6,838,100 1.75% — —
5 BNY GCM CLIENT ACCOUNT JPRD AC ISG 6,617,378 1.70% — —
6 株式会社SBI証券 5,035,417 1.29% — —
7 趙 鳳祥 1,990,700 0.51% — —
8 河合 裕 1,787,500 0.45% — —
9 望月 高清 1,463,400 0.37% — —
10 水野 親則 1,450,600 0.37% — —

Officers' holdings and pay

NameTitleSharesValuePay
山田 英 President & Representative Director 104,000 — —
佐藤 尚哉 Director — — —
栄木 憲和 Director — — —
原 誠 Director — — —
満倉 靖恵 Director — — —
森 郁夫 Audit & Supervisory Board Member — — —
林 清隆 Audit & Supervisory Board Member — — —
山梨 秀行 Audit & Supervisory Board Member — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 — ¥-14.44 — — 389,026,550
FY ending Dec 2024 — ¥-119.53 — — 286,377,550
FY ending Dec 2023 — ¥-39.29 12.8x — 198,470,300
Source: annual securities reports on EDINET. Values are estimates. Methodology